Trxade Group (MEDS)
NASDAQ:MEDS
Holding MEDS?
Track your performance easily

Trxade Group (MEDS) Cash flow

150 Followers

Trxade Group Cash Flow

MEDS's free cash flow for Q2 2024 was $4.22M. For the 2024 fiscal year, MEDS's free cash flow was decreased by $-89.50K and operating cash flow was $4.22M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -6.96M$ -2.07M$ -1.53M$ -2.57M$ -2.21M$ 141.78K
Investing Cash Flow
$ 26.81M$ -275.72K$ -427.85K$ -22.60K$ -37.51K$ -332.25K
Financing Cash Flow
$ -11.95M$ 1.41M$ -35.17K$ -208.18K$ 5.30M$ 2.19M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 11.44M$ 151.91K$ 1.13M$ 3.12M$ 5.92M$ 2.87M
Income Tax Paid Supplemental Data
----$ 0.00$ 0.00
Interest Paid Supplemental Data
$ 490.57K$ 733.69K$ 336.21K$ 28.34K$ 29.44K$ -98.46K
Issuance Of Capital Stock
--$ 130.92K-$ 5.99M$ 2.46M
Issuance Of Debt
$ 250.00K$ 250.00K-$ -225.00K--
Repayment Of Debt
$ -150.00K$ -150.00K-$ -225.00K$ 0.00$ -262.55K
Free Cash Flow
$ -6.96M$ -1.59M$ -1.50M$ -2.59M$ -2.25M$ 59.52K
Domestic Sales
------
Foreign Sales
------
Currency in USD

Trxade Group Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis